Elon's Next Millionaire-Making Project?
This could create more wealth than all of his previous ventures... combined.
Pauses on US foreign aid and local grants send funders and nonprofits scrambling
NEW YORK (AP) — Freezing . Withdrawing from the . Prohibiting nonprofits that receive U.S. foreign aid .
Families sue TikTok in France over teen suicides they say are linked to harmful content
CASSIS, France (AP) — In the moment when her world shattered three years ago, Stephanie Mistre found her 15-year-old daughter, Marie, lifeless in the bedroom where she died by suicide.
Retirement Planning for 2025 -- Act Now! - Ad
Make sure your retirement strategy is in place before 2025 rolls in. Let Datalign Advisory help you take charge of your financial future and get your ducks in a row before the year's end.
Gilgo Beach serial killing suspect seeks to bar DNA evidence and have separate trials in 7 deaths
NEW YORK (AP) — The New York architect facing murder charges in a known as the is challenging the DNA evidence against him and seeking separate trials in the sprawling case.
Trump White House Blames 'Outage' For Medicaid Website Lockout: 'We Have Confirmed No Payments Have Been Affected'
On Tuesday January 28, 2025, a federal health payment system lockout, blamed on an "outage," sparked criticism amid Trump's spending freeze, though payments were reportedly unaffected, according to the white house.
My TOP Altcoin for Right Now Is... - Ad
Searching for the top investment opportunity in crypto? Look no further. Our $3 report gives you the full scoop. You'll get this exciting token's name, our recommended investment strategy, and growth projections. Time is of the essence with this one...
Coca-Cola issues safety recall of soft drinks in Europe over chemical chlorate concerns
BRUSSELS (AP) — Coca-Cola has recalled some of its soft drinks in Europe after higher-than-normal levels of a chemical called chlorate were detected in bottles and cans at a production plant in Belgium.
What to know about Trump's first executive actions on climate and environment
President Trump's first week in office included with implications for Earth's climate and environment.
Get Your Retirement Plan in Shape in 2025 - Ad
The clock is ticking -- make the most of Q1 to set up a retirement plan that works for you. Datalign Advisory can help you get everything in order before tax time.
Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York Attorney General Letitia James announced Thursday.
Screen breaks and the right desk setup offer relief from work-related eye strain
NEW YORK (AP) — The trouble started every day at around 3 p.m., after Cathy Higgins had spent five or six hours staring at an array of computer screens at her desk. Her university job overseeing research projects involved peering closely at numbers and details on contracts, applications and budgets.
The No. 1 Stock for Trump's Second Term? - Ad
Legendary investor Louis Navellier's stock rating system gave a buy rating to ALL of the top 30 performing stocks in the S&P 500 index of Trump's first term... ALL of them! His system is now rating these stocks as a "BUY" for Trump's second term.
Thomas Tighe reflects on 24 years leading the international health nonprofit Direct Relief
SANTA BARBARA, Calif (AP) — Just days before ending his 24-year tenure as president and CEO of Direct Relief, Thomas Tighe was still so energized talking about delivering free medications to people who couldn't afford them that he seemed to forget he was standing inside an enormous “cold room,” set to a crisp 39 degrees Fahrenheit (4 degrees Celsius).
Donald Trump has sweeping plans for a second administration. Here's what he's proposed
WASHINGTON (AP) — has promised sweeping actions in his second administration.
Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad
The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.
Proposed rules would require nutrition info, allergen warnings on alcohol labels
Labels on wine, distilled spirits and malt beverages in the U.S. would be required to list alcohol content and nutritional information per serving, plus notification of potential allergens, under two new rules proposed Thursday by the Treasury Department.
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
FDA denies Vanda's Tradipitant application for gastroparesis, urging new trials for efficacy and safety. Vanda disputes the agency's review process.
He Called Bitcoin to $100k... Now He Says This Coin Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
UnitedHealth books better-than-expected fourth-quarter profit
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt.
What products contain Red 3 dye? Checking ingredient labels is the best way to find out
The Food and Drug Administration is ordering food and drug makers to called Red 3 from the products U.S. consumers eat and drink.
Legendary Investor: Buy These "Trump Stocks" Now - Ad
Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. According to legendary investor Louis Navellier, this is just the beginning of what could be the best four-year period for stocks in U.S. history.
How Biden's domestic policy record stacks up against public perception
WASHINGTON (AP) — President ends his term with a gulf between his policy record and his public reputation.
Interpol cracks down on illegal mining in West Africa as police make 200 arrests
PARIS (AP) — Interpol said Tuesday a major operation targeting in West Africa has resulted in 200 arrests and the seizure of harmful chemicals, explosives and drugs.
The Disaster Recovery Leader - Ad
From $15M+ contracts to booming scrap demand, this company is dominating a $42B market.
Moderna surprises the Street by predicting a bigger-than-expected sales drop
Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year.
Supreme Court to weigh reinstating Obamacare care requirements struck down by lower court
WASHINGTON (AP) — The Supreme Court agreed Friday to consider reinstating some preventative care coverage requirements under that were struck down by a lower court.
Unlocking a Polymetallic Discovery Like No Other - Ad
With drill results rivaling the best in the world and a fully funded 2025 program, this polymetallic stock is poised for major growth. Industry icons Robert Friedland and Rob McEwen are already in. Will you be next?
Stock Of The Day: Is Walgreens Breaking Out?
Shares of Walgreens (WBA) are trading higher on an earnings beat. They may be breaking the resistance around the $11 level.
Working Well: Saying no is hard, but setting boundaries can improve your health
NEW YORK (AP) — When Justin Stewart started his career, he juggled several jobs to make ends meet. He poured himself into his full-time role as a news show production assistant from 3 a.m. until noon. Then he rushed to the airport where he rented cars or to the big box stores where he pulled retail shifts.
The $20 Stock Powering NVIDIA, TESLA, and Microsoft - Ad
The biggest AI firms in the world... All rely on this single company. And right now, you can get in for only $20 - but not for long.
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals
AVITA Medical revises 2024 revenue guidance to $64.3 million, citing year-end inventory adjustments, and forecasts 2025 revenue growth of 55%-65% with new product launches.
How removing unpaid medical bills from credit reports could help consumers
NEW YORK (AP) — Lenders will no longer be able to consider unpaid medical bills as a credit history factor when they evaluate potential borrowers in the U.S. for mortgages, car loans or business loans, according to a rule the finalized Tuesday.
He Called Every Bull And Bear Market In Crypto Since 2012 ... Here's What He Says Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
FDA limits toxic lead in some baby foods
The U.S. Food and Drug Administration on Monday set maximum levels for lead in baby foods like jarred fruits and vegetables, yogurts and dry cereal, part of an effort to cut young kids' exposure to that causes developmental and neurological problems.
Surgeon General's Alcohol Cancer Warning And Dry January: This Cannabis Company Has You Covered
For Dry January, where consumers spend the month cutting back on alcohol, Curaleaf is expanding its zero-proof Hemp THC Seltzers.
Time for Financial Planning? Get a Free Match-Up with a Trusted Advisor! - Ad
Face the new year with confidence - work with a trusted advisor who can help you make smart decisions for your financial future. Datalign Advisory is here to guide you to a trusted advisor who can help every step of the way.
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
William Blair starts coverage on Denali Therapeutics with an Outperform rating, citing its transport vehicle platform and promising therapies for neurodegenerative diseases.
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
Eli Lilly moves to defend FDA's tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy claims.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.